Murine models of melanoma generated using IL-36γ overexpressing B16 cells displayed increased IFN-γ production and proliferation of CD8+ and CD4+ T cells following treatment with CTLA-4 monoclonal antibodies, compared to CTLA-4 or IL-36γ treatment alone [80]. The gene discussed is CTLA4; the disease is melanoma.